Adverse pulmonary vascular effects of high dose tricyclic antidepressants: acute and chronic animal studies

Liu X., Emery C.J., Laude E., Herget J., Gill G., Cope G., Barer G.R.

Source: Eur Respir J 2002; 20: 344-352
Journal Issue: August
Disease area: Pulmonary vascular diseases

Congress or journal article abstractPDF journal article, handout or slidesFull text journal article

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Liu X., Emery C.J., Laude E., Herget J., Gill G., Cope G., Barer G.R.. Adverse pulmonary vascular effects of high dose tricyclic antidepressants: acute and chronic animal studies. Eur Respir J 2002; 20: 344-352

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Reducing cholinergic constriction: the major reversible mechanism in COPD
Source: Eur Respir Rev 2006; 15: 32-36
Year: 2006



Pathophysiology and pharmacological treatment of pulmonary hypertension in acute respiratory distress syndrome
Source: Eur Respir J 2003; 21: 720-727
Year: 2003



Risk of myocardial infarction and cardiovascular death associated with inhaled corticosteroids in COPD
Source: Eur Respir J 2010; 35: 1003-1021
Year: 2010



Acute respiratory distress syndrome caused by pulmonary and extrapulmonary disease: effects of corticosteroid
Source: Eur Respir J 2002; 20: Suppl. 38, 36s
Year: 2002

The effect of long-term macrolides therapy for acute exacerbation of chronic obstructive pulmonary disease: A meta-analysis
Source: Annual Congress 2012 - Inflammation in airway diseases: diagnosis and management
Year: 2012

N-acetylcysteine reduces the risk of re-hospitalisation among patients with chronic obstructive pulmonary disease
Source: Eur Respir J 2003; 21: 795-798
Year: 2003



Low-dose inhaled corticosteroids and the risk of acute myocardial infarction in COPD
Source: Eur Respir J 2005; 25: 634-639
Year: 2005



Role of endothelial dysfunction, disturbance of haemostatic reactions in pathogenesis of acute exacerbation of chronic obstructive pulmonary disease (AE COPD)
Source: Annual Congress 2011 - Role of infection in exacerbations of COPD
Year: 2011

Acute exacerbation of chronic obstructive pulmonary disease and antibiotics: what studies are still needed?
Source: Eur Respir J 2002; 19: 966-975
Year: 2002



Acute respiratory failure during pregnancy
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=241
Year: 2006

Mechanisms of acute lung injury
Source: Annual Congress 2005 - In vivo - approaches to lung injury
Year: 2005

Pulmonary hypertension: future therapies
Source: ISSN=1025-448x, ISBN=1-904097-31-6, page=84
Year: 2004

Systemic effects of chronic obstructive pulmonary disease
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-48-0, page=224
Year: 2006

Short-term systemic steroid therapy in chronic obstructive pulmonary disease patients with acute respiratory failure
Source: Respiratory Failure and Mechanical Ventilation Conference 2020
Year: 2020



Reduced risk of next exacerbation and mortality associated with antibiotic use in COPD
Source: Eur Respir J 2009; 33: 282-288
Year: 2009



Effects of long-acting inhaled β-adrenergic and anticholinergic drugs on respiratory function and arterial blood gases in patients with COPD
Source: Annual Congress 2006 - Recent advances in the treatment of COPD
Year: 2006


Drugs (including oxygen) in severe COPD
Source: Eur Respir J 2008; 31: 1114-1124
Year: 2008



Obstructive pulmonary disease with acute respiratory failure
Source: ISSN=1025-448x, ISBN=1-904097-17-0, page=11
Year: 2001

Dose dependent increased mortality risk in COPD patients treated with oral glucocorticoids
Source: Eur Respir J 2001; 17: 337-342
Year: 2001